To evaluate the dose-response relationship and determine the optimal therapeutic dosage of the novel anticancer drug.
To study the pharmacokinetic variability across different biological conditions such as age, gender, and disease states.
To investigate the drug’s tissue targeting efficiency and accumulation in tumor versus healthy tissues.
To assess the safety profile and potential toxicity associated with repeated drug administration.
To develop and validate pharmacokinetic models for predicting drug behavior in human systems.
To examine the impact of formulation strategies on the drug’s bioavailability and stability.
Perform dose-escalation studies to analyze the relationship between dosage and plasma drug concentration.
Use analytical techniques (e.g., HPLC, mass spectrometry) to quantify drug concentration in biological samples.
Conduct tissue distribution studies to evaluate drug accumulation in various organs.
Assist in toxicity studies, including observation of adverse effects and biomarker analysis.
Develop pharmacokinetic models using software tools (e.g., PK/PD modeling software like Phoenix WinNonlin).
Compare pharmacokinetic data with existing anticancer drugs to benchmark performance.
Prepare graphical representations (e.g., concentration-time curves) for better interpretation of results.
Collaborate with cross-functional teams (e.g., pharmacologists, biochemists) for integrated analysis.
Document experimental protocols and maintain accurate laboratory records.
Present findings through reports, presentations, or research summaries.
